These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26526637)

  • 1. Blood-based Biomarkers at Large Bowel Endoscopy and Prediction of Future Malignancies.
    Kring TS; Piper TB; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Davis G; Dowell B; Johansen JS; Christensen IJ; Brünner N; Nielsen HJ
    Biomark Cancer; 2015; 7():57-61. PubMed ID: 26526637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy.
    Piper TB; Nielsen HJ; Christensen IJ
    Tumour Biol; 2022; 44(1):1-16. PubMed ID: 35180141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (†).
    Hvolris MH; Piper TB; Hammer E; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Christensen IJ; Brünner N; Johansen JS; Davis GJ; Dowell BL; Nielsen HJ
    Scand J Gastroenterol; 2016 Jul; 51(7):860-5. PubMed ID: 26918701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
    Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ
    Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
    Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
    Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
    Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.
    Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ;
    Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers?
    Wilhelmsen M; Christensen IJ; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klærke M; Nielsen KT; Laurberg S; Gawel S; Yang X; Davis G; Heijboer AM; Martens F; Nielsen HJ
    Biomark Cancer; 2018; 10():1179299X18776974. PubMed ID: 29872358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.
    Zhang H; Li H; Ma Q; Yang FY; Diao TY
    World J Gastroenterol; 2016 Oct; 22(39):8770-8778. PubMed ID: 27818592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.
    Spindler KL; Christensen IJ; Nielsen HJ; Jakobsen A; Brünner N
    Tumour Biol; 2015 Jun; 36(6):4301-8. PubMed ID: 25608838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
    Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients.
    Ye HM; Lu YZ; Liang XM; Lin YZ; Li Y; Zhang ZY; Tzeng CM
    Clin Lab; 2014; 60(3):397-405. PubMed ID: 24697115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort.
    Zhou G; Liu X; Wang X; Jin D; Chen Y; Li G; Li C; Fu D; Xu W; Wang X
    Onco Targets Ther; 2017; 10():1199-1206. PubMed ID: 28280354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB; Longlands MG; Wiener K; Shreeve DR
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
    Zhu FL; Ling AS; Wei Q; Ma J; Lu G
    Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis.
    Fuksiewicz M; Kotowicz B; Rutkowski A; Achinger-Kawecka J; Wagrodzki M; Kowalska MM
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818765209. PubMed ID: 29642772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients.
    Pesta M; Kucera R; Topolcan O; Karlikova M; Houfkova K; Polivka J; Macanova T; Machova I; Slouka D; Kulda V
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.